News | News By Subject | News by Disease News By Date | Search News

Inflammation (general) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Novartis AG (NVS) Granted Three Breakthrough Badges for Ilaris     4/27/2016
Amgen (AMGN) Deal Brings Xencor $45M Up Front, Setup for $1.7B in Milestones     9/16/2015
EXCLUSIVE: Cancer Therapy Benefits Realized Long After FDA Approval, Study Author Tells BioSpace (DHX)     6/29/2015
Aquinox (AQXP)’s Bladder Pain Drug Fails to Meet Statistical Endpoint in Phase II Trial     6/25/2015
Galapagos (GLPG.BR) Ends Long-Running R&D Inflammation Pact With Janssen Pharmaceutica N.V.     3/17/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Dynavax Technologies Corporation (DVAX) Regains Full Rights To Investigational TLR 7/9 Inhibitor DV1179 Following Expiration Of Collaboration With GlaxoSmithKline (GSK)     12/1/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Novartis Pharmaceutical Corporation (NVS) AIN457 (secukinumab) Showed Significant Symptom Improvement In Two Pivotal Phase 3 ankylosing spondylitis Studies     11/17/2014
TxCell Achieves Positive Results For Col-Treg In A Model Of Autoimmune Uveitis     10/28/2014
Ablynx (ABLYF)'s Ant-Il-6R Nanobody Partnered With AbbVie (ABBV) Demonstrates A Bioavailability Of More Than 80% After Subcutaneous Injection     10/23/2014
Soligenix (SNGX) Awarded National Institute of Allergy And Infectious Diseases (NIAID) Contract Valued Up To $24.7 Million     9/19/2014
Innapharma: Completion Of Target Enrollment In The Phase 2 EffiKIR Trial     7/24/2014
Ablynx (ABLYF) Scores $840 Million Inflammatory Drug Pact With AbbVie (ABBV); Ablynx Stock Rises 24.73% at Market Close (September 23, 2013)     9/23/2013

News from Around the Web
Frequent Nut Consumption Associated With Less Inflammation, Brigham and Women's Hospital Study     8/3/2016
FDA Proposes Ban On Most Powdered Medical Gloves     3/22/2016
The Science Of Why Your Muscles Get Less Sore As You Stick With Your Gym Routine, Brigham Young University Study     2/9/2016
Inflammation Can Fan The Flames Of Depression, Rice University Study     12/21/2015
Inflammation May Bring On Depression Symptoms, Emory University School of Medicine Study     11/23/2015
Could A Pill Make Bacon As Beneficial As Fish Oil? University of Gothenburg Study     8/28/2015
If You Want To Reach 100, Keep Your Inflammation Levels Low, Newcastle University Study     8/10/2015
Drinking Coffee May Lower Inflammation, Diabetes Risk, Harokopio University     7/21/2015
Mothers Can Pass Traits To Offspring Through Bacteria's DNA, Washington University in St. Louis Study     2/23/2015
Yale University School Of Medicine Team Identifies Link Between Inflammation And Type 2 Diabetes     2/10/2015
Use Nature, Art, And Religion To Boost Your Body's Defense System, University of California, Berkeley (CAL) Study     2/6/2015
Personality And Health May Have A Genetic Link, University of Nottingham Study     12/12/2014
Novel Treatment To Decrease Craving In Alcoholics Identified, Université Catholique de Louvain Study     10/31/2014
Over-The-Counter Pain Med May Restore Immune Function In Old Age, Ohio State University Study     9/3/2014
Aspirin's Second Effect: Reduces Inflammation, University of California, San Diego (UCSD) Study     8/20/2014

Press Releases
Aldeyra (ALDX) To Present Novel Data On The Anti-Inflammatory Mechanism And Activity Of ADX-102 At The World Congress On Inflammation 2017 Annual Meeting     6/19/2017
Entest Biomedical, Inc.'s Subsidiary EnteroMedics (ETRM) Reports On Preliminary Canine Experiments Testing New Anti-Inflammatory Drug Compounds     6/7/2017
Immunexpress Release: Four-Biomarker Signature Differentiates Viral And Non-Viral Causes Of Systemic Inflammation     6/6/2017
Sobi Canada (B6E.F) Release: Kineret Approved In Canada For The Treatment Of Neonatal-Onset Multisystem Inflammatory Disease (NOMID)     5/30/2017
Kenneth Rainin Foundation Announces Grant Opportunity For Collaborative Research Projects Related To Inflammatory Bowel Disease     5/30/2017
Cincinnati Children's Hospital Medical Center Release: Experimental Drug Targets Nucleus Of Allergen-Sensitized Cells     4/19/2017
Galapagos (GLPG.BR) Announces Three New Phase II Proof-Of-Concept Studies With Filgotinib     4/4/2017
Nektar Therapeutics (NKTR) Initiates Clinical Study Of NKTR-358, A First-In-Class Regulatory T Cell Stimulator, Being Developed For The Treatment Of Immune And Inflammatory Disorders     3/27/2017
Amgen (AMGN) Release: European Commission (EC) Approves Amgevita (Biosimilar Adalimumab) For The Treatment Of Certain Inflammatory Diseases     3/24/2017
Corbus (CRBP) To Present Gene Expression Data From Recent Phase II Systemic Sclerosis Study Demonstrating JBT-101 Inhibits Inflammation And Fibrosis Pathways     3/8/2017
UCB, Inc. (UCBJF.PK) Release: First CIMZIA (Certolizumab Pegol) Study Of Its Kind Showed Minimal To No Transfer Of Drug From Mother's Plasma To Breast Milk     3/6/2017
CSL Behring Release: Largest Ever CIDP Clinical Study Completed     3/1/2017
Cincinnati Children's Hospital Medical Center Release: Nature Study Suggests New Therapy For Gaucher Disease     2/23/2017
Cleveland HeartLab LLC Adds New Patent To Its Extensive Intellectual Property Position For The Myeloperoxidase (MPO) Test, A Powerful Biomarker For Inflammation And Its Role In Major Cardiac Events     2/22/2017
Windtree Therapeutics (WINT)' Aerosolized KL4 Surfactant Reduces Lung Inflammation And Improves Survival In A High-Pathogen Avian Influenza Preclinical Study     2/16/2017